<DOC>
	<DOCNO>NCT01333865</DOCNO>
	<brief_summary>The main objective study evaluate safety effectiveness memantine ( Namenda® ) cognitive behavioral impairment adult age 18-50 year autism spectrum disorder ( ASD ) . This exploratory , 12-week , pilot study , seek determine whether Namenda efficacious well tolerate treatment adult ASD . The study result use generate hypothesis large randomize control clinical trial explicit hypotheses sufficient statistical power .</brief_summary>
	<brief_title>A Study Memantine Hydrochloride ( Namenda® ) Cognitive Behavioral Impairment Adults With Autism Spectrum Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Inclusions Male female outpatient 1850 year age . Participants must DSMIVTR diagnosis PDD display PDD symptom least moderate impairment ( SRS score ≥ 85 CGIPDD ≥ 4 ) . Fulfills diagnosis autism spectrum disorder meet DSMIVTR PDD diagnostic criterion autistic disorder ( exception total lack spoken language ) , Asperger 's disorder , PDDNOS establish clinical interview confirm DICAR PDD module . Subjects and/or legal representative must level understanding sufficient communicate intelligently investigator study coordinator , cooperate test examination require protocol . Subjects and/or legal representative must consider reliable reporter . Each subject and/or authorized legal representative must understand nature study . The subject and/or legal representative must sign informed consent document . Subject must able participate mandatory blood draw . Subject must able swallow pill . Subjects mood , anxiety , disruptive behavior disorder allow participate study provide meet exclusionary criterion . Exclusions IQ &lt; 85 . Total lack spoken language . DSMIVTR PDD diagnose Rett 's disorder , childhood disintegrative disorder . Clinically unstable psychiatric condition judge serious suicidal risk . Active symptom anorexia bulimia nervosa Current diagnosis psychotic disorder unstable bipolar disorder . History recent current ( past 30 day ) clinically significant depressive anxiety disorder warrant treatment . Current diagnosis schizophrenia . History substance use ( except nicotine caffeine ) within past 3 month Serious , stable unstable systemic illness include hepatic , renal , gastroenterological , respiratory , cardiovascular ( include ischemic heart disease ) , endocrinologic , neurologic , immunologic , hematologic disease . Subjects severe hepatic impairment ( LFTs &gt; 3 time ULN ) severely impaired renal function ( eGFR &lt; 30 ) . Subjects genitourinary condition raise urine pH ( e.g. , renal tubular acidosis , severe infection urinary tract ) . Uncorrected hypothyroidism hyperthyroidism . Subjects untreated and/or unstable diabetes . Nonfebrile seizures without clear resolve etiology . Pregnant nursing female . Known hypersensitivity memantine . Severe allergy multiple adverse drug reaction . A nonresponder history intolerance memantine , treatment adequate dos determine clinician . Investigator his/her immediate family define investigator 's spouse , parent , child , grandparent , grandchild .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Memantine</keyword>
	<keyword>Namenda</keyword>
	<keyword>Autism Spectrum Disorders</keyword>
	<keyword>Pervasive Developmental Disorders</keyword>
	<keyword>Adults</keyword>
</DOC>